R10131 |
Momelotinib (CYT387) |
Momelotinib (CYT387) 是 ATP 竞争性的 JAK1/JAK2 抑制剂,IC50 值分别为 11 nM/18 nM,是对 JAK3 选择性的
|
R10132 |
Canagliflozin |
Canagliflozin is a highly potent and selective SGLT2 inhibitor for hSGLT2 with I
|
R10136 |
Torkinib;PP242 |
Torkinib (PP 242) 是选择性,ATP竞争型的 mTOR 抑制剂,IC50 为 8 nM。PP242 抑制 mTORC1 和 mTORC2 的 I
|
R10137 |
AP23464 |
|
R10138 |
Tivozanib;AV-951; KRN951 |
Tivozanib (AV-951; KRN951) 是有效,选择性的 VEGFR 1/2/3 抑制剂,IC50 值分别为0.21,0.16,and 0.24
|
R10139 |
Roscovitine; Seliciclib |
Roscovitine (Seliciclib, CYC202) is a potent and selective CDK inhibitor for Cdc
|
R10140 |
Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) |
Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) 是HCV NS5A高度选择性抑制剂,EC50为
|
R10141 |
SB705498 |
SB705498 is a TRPV1 antagonist for hTRPV1, antagonizes capsaicin, acid, and heat
|
R10143 |
Cabozantinib (XL184; BMS-907351) |
Cabozantinib是一种有效的多受体酪氨酸激酶抑制剂, 抑制VEGFR2,c-Met,Kit,Axl 和 Flt3 的 IC50 分别为0.035,1.3
|
R10145 |
ABT102 |
|
R10146 |
XL765 |
Voxtalisib (SAR245409, XL765) is a dual inhibitor of mTOR/PI3K, mostly for p110γ
|
R10147 |
LY335979 |
Zosuquidar (LY335979) is a potent modulator of P-glycoprotein-mediated multi-dru
|
R10149 |
替卡格雷;Ticagrelor (AZD6140; AR-C 126532XX) |
Ticagrelor (AZD6140)是可逆有口服活性的 P2Y12 受体拮抗剂,可用来治疗血小板聚集。
|
R10150 |
Ceritinib; LKD378 |
Ceritinib (LDK378) 是一种选择性,口服可生物利用且具有 ATP 竞争性的 ALK 酪氨酸激酶抑制剂,IC50 为 200 pM。 Ceriti
|
R10151 |
E7080; Lenvatinib |
Lenvatinib (E7080) is a multi-target inhibitor, mostly for VEGFR2(KDR)/VEGFR3(Fl
|
R10152 |
Neratinib; HKI272 |
Neratinib 是一种可口服的,不可逆的 tyrosine kinase 抑制剂,能够抑制 HER2 和 EGFR 的活性,IC50 值分别为 59 nM
|
R10153 |
Roxadustat (FG-4592) |
Roxadustat (FG-4592) 是一种口服 低氧诱导因子脯氨酰羟化酶 抑制剂 (HIF-PHI),通过增加内源性促红细胞生成素、改善铁调节和降低铁调素
|
R10154 |
CTP518 |
|
R10155 |
Posaconazole; SCH56592; Noxafil |
Posaconazole 是一种广谱的,二代三唑类物质,具有抗真菌作用。
|
R10156 |
Nintedanib; BIBF1120 |
Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3,
|
R10157 |
AZD9291 Intermediate1 |
Osimertinib (AZD9291) is an oral, irreversible, and mutant-selective EGFR inhibi
|
R10158 |
AZD9291 Intermediate2 |
Osimertinib (AZD9291) is an oral, irreversible, and mutant-selective EGFR inhibi
|
R10159 |
Anacetrapib; MK0859 |
Anacetrapib 是一种有效的 CETP 抑制剂,作用于 rhCETP 和 C13S CETP 突变型,IC50 分别为 7.9±2.5 nM 和 11.
|
R10160 |
Omarigliptin; MK3102 |
Omarigliptin(MK-3102)是DPP4高效选择性抑制剂,IC50值为1.6nM。
|
R10162 |
Apremilast; CC10004 |
Apremilast (CC-10004) is a potent and orally active PDE4 and TNF-α inhibitor wit
|